Jun 13, 2023 / 03:40PM GMT
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Okay. Let's get underway. Good morning, everybody. Welcome to the second day of the 44th Annual Goldman Sachs Healthcare Conference. We are very pleased to have Bristol-Myers join us. Today from the team an opportunity to really focus in on some of the key business segments, we have Lynelle Hoch, Senior Vice President, Global Cell Therapy franchise live in in-person, you were impressive on Zoom at ASCO; and Roland Chen, who is an SVP in the cardiovascular development, also a very strategic pillar in terms of the portfolio for Bristol.
So what I'd like to do is make these conversations some connectivity that you're not just mouthpieces for Tim and Nina, but we know a little bit about who you are, where you came from. So a quick snap so on your professional journey that brings to bear so that we know how you think about stuff to communicate what's been in your dark and mysterious past? Lynelle you first.
Lynelle Hoch -
okay. My dark and mysterious past. So Lynelle Hoch, I've been at
Bristol-Myers Squibb Co at Goldman Sachs Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers